Penalizing hospitals for chronic obstructive pulmonary disease readmissions

Area of Science:

• Health Policy
• Pulmonology
• Healthcare Management

Background:

• The Centers for Medicare and Medicaid Services (CMS) is expanding the Hospital Readmission Reduction Program (HRRP) to include chronic obstructive pulmonary disease (COPD).
• Hospitals face financial penalties for high 30-day all-cause unplanned readmission rates following COPD exacerbations.
• This policy impacts Medicare beneficiaries and healthcare providers.

Purpose of the Study:

• To review the history and expansion of the HRRP to include COPD.
• To critically assess the 30-day all-cause COPD readmission measure as an accountability metric.
• To discuss potential benefits, drawbacks, and unintended consequences of this policy.

Main Methods:

• Perspective piece reviewing policy history and literature.
• Critical analysis of the 30-day COPD readmission measure.
• Discussion of potential impacts on stakeholders.

Main Results:

• The HRRP's inclusion of COPD readmissions presents potential benefits but also substantial drawbacks.
• Unintended consequences may adversely affect providers, hospitals, and patients with COPD.
• The current measure may not fully capture quality of care post-discharge.

Conclusions:

• The 30-day COPD readmission measure requires careful contextualization within broader quality frameworks.
• A reconceived model for post-discharge quality is needed.
• Alternative frameworks should be explored to guide quality assessment and improvement for COPD patients.